Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Allergy Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Allergy Other
    Inhaled Ciclesonide Improves Asthma Control: Presented at ACAAI - (DGDispatch)
    Efficacy of Aqueous Triamcinolone Acetonide in Allergic Rhinitis Not Affected by Gender: Presented at ACAAI - (DGDispatch)
    FDA Approves a C1-Esterase Inhibitor for Abdominal Attacks, Facial Swelling Associated With HAE - (DGNews)
    FDA Approves Bepotastine Besilate Solution for Ocular Itching Associated With Allergies - (DGNews)
    FDA Approves Levocetirizine Dihydrochloride for Paediatric Nasal Allergies - (DGNews)

    News archive

     Recent webcasts/CME - Allergy Other
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • Advances in Hereditary Angioedema Treatment: Considerations, Criteria & the New Therapy Options for Treatment & Prevention of HAE Attacks
      Sublingual Immunotherapy (SLIT) for Allergic Rhinitis The Latest Evidence
      Update in Hereditary Angioedema: A Disease in Rapid Evolution

      Webcasts/CME archive

       Recent cases - Allergy Other
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Anaphylaxis Following Intravenous Fluorescein Angiography in a Vitreoretinal Clinic: Report of 4 Cases
        Acute Allergic Reaction due to Milk Proteins Contaminating Lactose Added to Corticosteroid for Injection
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        Anaphylactic Reaction to Camomile Tea

        Cases archive
          




        my personal edition > allergy other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Impermeable Bed Cover Use Does Not Lead to Improved Symptoms for Patients with Asthma or Allergic Rhinitis

        A DGReview of :"Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma"
        New England Journal of Medicine (NEJM)

        07/21/2003
        By Joene Hendry


        Bed covers that are impermeable to mite allergens reduce the level of exposure to dust-mite allergen, the results of two studies show.

        Using bed covers as a single avoidance measure, however, does not offer a significant improvement in clinical symptoms of patients with asthma or allergic rhinitis.

        Ashley Woodcock, MD, of the University of Manchester, United Kingdom, and colleagues analysed the efficacy of mite allergen impermeable bed covers versus non-impermeable covers in 1,122 adults with asthma.

        The 560 patients randomised to use impermeable bed covers had a prevalence of sensitivity to dust-mite allergen of 65.4%, while this prevalence was 65.1% in the 562 participants using normal covers.

        After 6 months of use the concentration of Dermatophagoides pteronyssinus 1 (Der p1) in mattress dust was significantly lower in the impermeable cover group (geometric mean of 0.58 mcg/g) versus control (geometric mean of 1.71 mcg/g). However by 12 months there was no significant difference between groups (1.05 mcg/g in the impermeable group and 1.64 mcg/g in control).

        At 6 months, mean morning peak expiratory flow rates in both groups improved significantly over baseline -- from 410.7 to 419.1 L/minute in the impermeable cover group and from 417.8 to 427.4 L/minute in control. However, the researchers noted no significant differences between the groups in morning peak expiratory flow rates or in the use of beta-agonists, in the rates of exacerbations, or in symptom and quality-of-life scores.

        At 12 months the groups showed no significant difference in the proportion ceasing to use inhaled corticosteroid therapy or in the mean reduction in steroid dose.

        In the absence of other mite-control measures, impermeable bed covers are clinically ineffective for the routine management of adults with asthma. "No effect was seen," Dr. Woodcock and colleagues write, "even in the subgroup of patients with high levels of mite-specific IgE and high levels of exposure to mite allergens."

        In a related study, Roy Gerth van Wijk, MD, PhD, of Erasmus Medical Center, Rotterdam, Netherlands, and colleagues analysed the effects of mite-proof bed covers on the symptoms and signs of allergic rhinitis in 279 mite-sensitive patients 8 to 50 years old.

        The patients were randomised to use impermeable or non-impermeable covers for their mattress, pillow, and duvet or blanket. The researchers measured concentrations of Der p1 and of D. farinae (Der f1), at baseline and after 12 months, in the patients' mattresses and bedroom and living room floors.

        Among the 232 participants who completed the study, the geometric mean concentration of Der p1 and Der f1 in the mattress samples was significantly lower from baseline in the impermeable group (from 49.64 to 38.74 mcg/g of dust) compared with the non-impermeable group (from 44.07 to 32.32 mcg/g of dust).

        Dust mite reductions were evident in the bedroom floor dust of the group using the impermeable covers but not in the non-impermeable cover group.

        The researchers noted a significant decrease in mean score on the rhinitis-specific visual-analogue scale in both study groups (P<0.001 for both groups). But they found no significant difference between groups on the rhinitis-specific visual-analogue, the nasal allergen-provocation, or in the daily symptom scores.

        This trial, "demonstrated a lack of clinical effect of mite-proof covers for mattresses, pillows, and duvets on signs and symptoms of rhinitis," Dr. Gerth van Wijk and colleagues write, "despite a significant reduction (by a factor of 2.6) in the level of exposure to house-dust mites in the mattress."

        Related Link: Evaluation of impermeable covers for bedding in patients with allergic rhinitis (N Engl J Med 2003;349:3:237-46).
        N Engl J Med 2003;349:3:225-36. "Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send